chr1-181721870-G-A
Variant summary
The NM_001205293.3(CACNA1E):c.2069G>A (p.Gly690Asp) variant causes a missense change involving the alteration of a conserved nucleotide. The gene CACNA1E is a known oncogene (CancerMine: 1 oncogene citations). The variant is absent from the gnomAD population database at sites with sufficient sequencing coverage. In-silico predictor (REVEL) classifies this variant as likely damaging/oncogenic. Splicing prediction tools (SpliceAI) predict no significant impact on normal splicing. The affected nucleotide is highly conserved across species (PhyloP 100-way vertebrate score: 8.02). Variant has been reported in ClinVar as Uncertain Significance (★). A different missense at the same amino acid position has been reported as Pathogenic/Likely Pathogenic in ClinVar: p.G690V: Likely_pathogenic (ClinVar VariationId 1346057, 1 star) The variant has been observed in cBioPortal in 1 sample across 1 study and 1 cancer type; somatic enrichment level: NONE (Observed in at most one deduplicated cBioPortal case.). This exact variant is curated in the UniProt human variants database as Uncertain Significance; it is also listed as a COSMIC curated somatic variant.
Frequency
Consequence
NM_001205293.3 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 69Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Illumina, Labcorp Genetics (formerly Invitae)
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- neurodevelopmental disorderInheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
Genome browser will be placed here
Classification according to ACGS-UK Somatic Oncogenicity v2025
Our verdict: Uncertain_significance. The variant received 4 points.
| Apply | Criterion Code & Title / Strength | Rationale / Clinical Context | |
|---|---|---|---|
| O3Absent or very rare in population | Absent or extremely rare in gnomAD (AC ≤ 2) — O3 moderate; GnomAD: AF = absent, AC = 0 — absent/extremely rare (O3 moderate [+2]) | ||
| O6Computational evidence supports deleterious effect | Computational evidence supports a deleterious/oncogenic effect; Missense variant — primary computational scorer supports an oncogenic/deleterious effect | ||
| O7Mutational hotspot or critical domain | Supporting: cancerhotspots.org hit, critical domain, or missense neighbourhood hotspot; No cancerhotspots.org hit at this position; UniProt domain: 0 pathogenic, 0 benign.; ±8 AA neighbourhood: 2 pathogenic, 1 benign (OR vs. background: 8.3); Variant does not impact splicing — splice-hotspot path not applicable |
Variant Effect in Transcripts
Automated classification analysis was done for transcript: NM_001205293.3. You can select a different transcript below to see updated classification assignments.
RefSeq Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
CACNA1E | MANE Select | c.2069G>A p.Gly690Asp | missense | Exon 16 of 48 | Prot: NP_001192222.1 UniProt: | |
CACNA1E | c.2069G>A p.Gly690Asp | missense | Exon 16 of 47 | Prot: NP_000712.2 UniProt: | ||
CACNA1E | c.2069G>A p.Gly690Asp | missense | Exon 16 of 46 | Prot: NP_001192223.1 UniProt: |
Ensembl Transcripts
| Sel. | Gene / Transcript | Tags | HGVSc / HGVSp | Effect | Exon rank | Protein / UniProt |
|---|---|---|---|---|---|---|
CACNA1E | TSL:1MANE Select | c.2069G>A p.Gly690Asp | missense | Exon 16 of 48 | Prot: ENSP00000356545.2 UniProt: | |
CACNA1E | TSL:5 | c.2069G>A p.Gly690Asp | missense | Exon 16 of 47 | Prot: ENSP00000353222.3 UniProt: | |
CACNA1E | TSL:1 | c.2069G>A p.Gly690Asp | missense | Exon 16 of 47 | Prot: ENSP00000356542.1 UniProt: |
Frequencies
Allele frequencies (AF), counts (AC/AN), homozygotes and coverage
| Source / population | AF | AC | Hom | AN | Coverage |
|---|---|---|---|---|---|
Global population databases 5 sources | |||||
GnomAD3 genomes | Cov:32 | ||||
GnomAD4 exome | Cov:27 | ||||
GnomAD4 genome | Cov:32 | ||||
TOPMed (Bravo) | AF: 0.00000378 | AC:1 | Hom:0 | AN:264690 | |
ALFA (dbGaP/dbSNP Allele Frequency Aggregator) | AF: 0.00 | AC:0 | Hom:0 | AN:14846 | |
ClinVar
Computational Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
AlphaGenome AVI | Pathogenic | 30 | |
AlphaMissense | Pathogenic | 1.0 | |
BayesDel_addAF | Pathogenic | 0.57 | D |
BayesDel_noAF | Pathogenic | 0.58 | |
CADD | Pathogenic | 26 | |
DANN | Uncertain | 1.0 | |
DEOGEN2 | Pathogenic | 0.99 | D |
Eigen | Pathogenic | 1.0 | |
Eigen_PC | Pathogenic | 0.92 | |
FATHMM_MKL | Pathogenic | 0.99 | D |
FuncVEP CTI | Pathogenic | 1.0 | |
GPN-Star LLR | N/A | -9.2 | |
GPN-Star score | N/A | 9.2 | |
LIST_S2 | Pathogenic | 0.99 | D |
M_CAP | Pathogenic | 0.91 | D |
MetaRNN | Pathogenic | 0.98 | D |
MetaSVM | Pathogenic | 1.0 | D |
Mutation Taster | N/A | 1/99 | disease causing |
MutationAssessor | Pathogenic | 3.6 | H |
PhyloP100 | Pathogenic | 8.0 | |
popEVE | Pathogenic | -5.2 | |
PrimateAI | Pathogenic | 0.94 | D |
PROVEAN | Pathogenic | -6.1 | D |
REVEL | Pathogenic | 0.97 | |
Sift | Uncertain | 0.0050 | D |
Sift4G | Uncertain | 0.0060 | D |
Varity_R | N/A | 0.79 | |
VESM-3B | Benign | -14 |
Splicing Scores
| Algorithm | Calibrated pred. | Score | Prediction |
|---|---|---|---|
Pangolin (max) | Benign | 0.040 | |
SpliceAI score (max) | Benign | 0.010 | Details are displayed if max score is > 0.2 |
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.